These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11828860)

  • 41. Understanding Antiretroviral Treatment Adherence Among HIV-Positive Women at Four Postpartum Time Intervals: Qualitative Results from the Kabeho Study in Rwanda.
    Gill MM; Umutoni A; Hoffman HJ; Ndatimana D; Ndayisaba GF; Kibitenga S; Mugwaneza P; Asiimwe A; Bobrow EA
    AIDS Patient Care STDS; 2017 Apr; 31(4):153-166. PubMed ID: 28358624
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Emergence of antiretroviral resistance in HIV-positive women receiving combination antiretroviral therapy in pregnancy.
    Lyons FE; Coughlan S; Byrne CM; Hopkins SM; Hall WW; Mulcahy FM
    AIDS; 2005 Jan; 19(1):63-7. PubMed ID: 15627034
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ensuring HIV-infected pregnant women start antiretroviral treatment: an operational cohort study from Lilongwe, Malawi.
    Weigel R; Hosseinipour MC; Feldacker C; Gareta D; Tweya H; Chiwoko J; Gumulira J; Kalulu M; Mofolo I; Kamanga E; Mwale G; Kadzakumanja A; Jere E; Phiri S
    Trop Med Int Health; 2012 Jun; 17(6):751-9. PubMed ID: 22487553
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adherence among women with HIV infection in Puerto Rico: the potential use of modified directly observed therapy (MDOT) among pregnant and postpartum women.
    Ciambrone D; Loewenthal HG; Bazerman LB; Zorilla C; Urbina B; Mitty JA
    Women Health; 2006; 44(4):61-77. PubMed ID: 17456464
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Implementation and Operational Research: Postpartum Transfer of Care Among HIV-Infected Women Initiating Antiretroviral Therapy During Pregnancy.
    Phillips T; McNairy ML; Zerbe A; Myer L; Abrams EJ
    J Acquir Immune Defic Syndr; 2015 Nov; 70(3):e102-9. PubMed ID: 26470033
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Factors associated with antiretroviral treatment initiation amongst HIV-positive individuals linked to care within a universal test and treat programme: early findings of the ANRS 12249 TasP trial in rural South Africa.
    Boyer S; Iwuji C; Gosset A; Protopopescu C; Okesola N; Plazy M; Spire B; Orne-Gliemann J; McGrath N; Pillay D; Dabis F; Larmarange J;
    AIDS Care; 2016; 28 Suppl 3(Suppl 3):39-51. PubMed ID: 27421051
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention.
    Fowler MG; Qin M; Fiscus SA; Currier JS; Flynn PM; Chipato T; McIntyre J; Gnanashanmugam D; Siberry GK; Coletti AS; Taha TE; Klingman KL; Martinson FE; Owor M; Violari A; Moodley D; Theron GB; Bhosale R; Bobat R; Chi BH; Strehlau R; Mlay P; Loftis AJ; Browning R; Fenton T; Purdue L; Basar M; Shapiro DE; Mofenson LM;
    N Engl J Med; 2016 Nov; 375(18):1726-1737. PubMed ID: 27806243
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The impact of HBV or HCV infection in a cohort of HIV-infected pregnant women receiving a nevirapine-based antiretroviral regimen in Malawi.
    Andreotti M; Pirillo MF; Liotta G; Jere H; Maulidi M; Sagno JB; Luhanga R; Amici R; Mancini MG; Gennaro E; Marazzi MC; Vella S; Giuliano M; Palombi L; Mancinelli S
    BMC Infect Dis; 2014 Apr; 14():180. PubMed ID: 24708626
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Factors affecting adherence to antiretroviral therapy among pregnant women in the Eastern Cape, South Africa.
    Adeniyi OV; Ajayi AI; Ter Goon D; Owolabi EO; Eboh A; Lambert J
    BMC Infect Dis; 2018 Apr; 18(1):175. PubMed ID: 29653510
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reliability of absolute lymphocyte count as a marker to assess the need to initiate antiretroviral therapy in HIV-infected children.
    Shah I; Parikh S
    J Postgrad Med; 2012; 58(3):176-9. PubMed ID: 23023348
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Baseline clinical characteristics, antiretroviral therapy use, and viral load suppression among HIV-positive young men of color who have sex with men.
    Hightow-Weidman LB; Jones K; Phillips G; Wohl A; Giordano TP;
    AIDS Patient Care STDS; 2011 Aug; 25 Suppl 1(Suppl 1):S9-14. PubMed ID: 21711145
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Factors Associated with Postpartum Loss to Follow-Up and Detectable Viremia After Delivery Among Pregnant Women Living with HIV.
    Adhikari EH; Yule CS; Roberts SW; Rogers VL; Sheffield JS; Kelly MA; McIntire DD; Barnes A
    AIDS Patient Care STDS; 2019 Jan; 33(1):14-20. PubMed ID: 30601060
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-Term Outcomes of HIV-Infected Women Receiving Antiretroviral Therapy After Transferring Out of an Integrated Maternal and Child Health Service in South Africa.
    Phillips TK; Mogoba P; Brittain K; Gomba Y; Zerbe A; Myer L; Abrams EJ
    J Acquir Immune Defic Syndr; 2020 Mar; 83(3):202-209. PubMed ID: 31725060
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Seven year review of retention in HIV care and treatment in federal medical centre Ido-Ekiti.
    Babatunde O; Ojo OJ; Atoyebi OA; Ekpo DS; Ogundana AO; Olaniyan TO; Owoade JA
    Pan Afr Med J; 2015; 22():139. PubMed ID: 26889320
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adverse events in a cohort of HIV infected pregnant and non-pregnant women treated with nevirapine versus non-nevirapine antiretroviral medication.
    Aaron E; Kempf MC; Criniti S; Tedaldi E; Gracely E; Warriner A; Kumar R; Bachmann LH
    PLoS One; 2010 Sep; 5(9):e12617. PubMed ID: 20838641
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Determination of optimized multidisciplinary care team for maximal antiretroviral therapy adherence.
    Horberg MA; Hurley LB; Towner WJ; Allerton MW; Tang BT; Catz SL; Silverberg MJ; Quesenberry CP
    J Acquir Immune Defic Syndr; 2012 Jun; 60(2):183-90. PubMed ID: 22293551
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies.
    Braithwaite RS; Kozal MJ; Chang CC; Roberts MS; Fultz SL; Goetz MB; Gibert C; Rodriguez-Barradas M; Mole L; Justice AC
    AIDS; 2007 Jul; 21(12):1579-89. PubMed ID: 17630553
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence of anemia and correlation with biomarkers and specific antiretroviral regimens in 9690 human-immunodeficiency-virus-infected patients: findings of the Anemia Prevalence Study.
    Mildvan D; Creagh T; Leitz G;
    Curr Med Res Opin; 2007 Feb; 23(2):343-55. PubMed ID: 17288689
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CD4 cell response to antiretroviral therapy in children with vertically acquired HIV infection: is it associated with age at initiation?
    Newell ML; Patel D; Goetghebuer T; Thorne C;
    J Infect Dis; 2006 Apr; 193(7):954-62. PubMed ID: 16518757
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effectiveness of antiretroviral therapy in HIV-infected children under 2 years of age.
    Penazzato M; Prendergast A; Tierney J; Cotton M; Gibb D
    Cochrane Database Syst Rev; 2012 Jul; (7):CD004772. PubMed ID: 22786492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.